Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Follow-up Study of Patients With Spinal Muscular Atrophy Receiving Risdiplam Treatment

NCT05232929 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT05232929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05232929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Follow-up Study of Patients With Spinal Muscular Atrophy Receiving Risdiplam Treatment
Lead sponsor
Genentech, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 29, 2022
Completion date
October 2, 2026
Enrollment
403 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

spinal muscular atrophy